Inadequate reporting of COVID-19 clinical studies: a renewed rationale for the Sex and Gender Equity in Research (SAGER) guidelines
Open Access
- 12 April 2021
- journal article
- editorial
- Published by BMJ in BMJ Global Health
- Vol. 6 (4) , e004997
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health Research
- European Union (872396)
This publication has 16 references indexed in Scilit:
- Reporting of sex-specific outcomes in trials of interventions for cardiovascular disease: Has there been progress?Maturitas, 2021
- Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and responseVaccine, 2021
- Lack of consideration of sex and gender in clinical trials for COVID-19medRxiv, 2020
- Inclusion of pregnant women in COVID-19 vaccine developmentThe Lancet Infectious Diseases, 2020
- Excess mortality in men and women in Massachusetts during the COVID-19 pandemicThe Lancet, 2020
- Towards Precision Medicine: Inclusion of Sex and Gender Aspects in COVID-19 Clinical Studies—Acting Now before It Is Too Late—A Joint Call for ActionInternational Journal of Environmental Research and Public Health, 2020
- Sex and gender reporting in global health: new editorial policiesBMJ Global Health, 2018
- Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended useResearch Integrity and Peer Review, 2016
- Taking sex into account in medicineThe Lancet, 2011
- Cardiovascular health advice for children in the USAThe Lancet, 2011